Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis.
Giovanni CaocciOlga MulasDaniela MantovaniAlessandro CostaAndrea GaliziaLuca BarabinoMarianna GrecoRoberta MurruGiorgio La NasaPublished in: Annals of hematology (2021)